Skip to main content
DIRUI INDUSTRIAL CO.,LTD. logo

DIRUI INDUSTRIAL CO.,LTD. — Investor Relations & Filings

Ticker · 300396 ISIN · CNE100001XS7 Shenzhen Stock Exchange Manufacturing
Filings indexed 1,689 across all filing types
Latest filing 2020-06-30 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 300396

About DIRUI INDUSTRIAL CO.,LTD.

https://www.dirui.com.cn

DIRUI INDUSTRIAL CO.,LTD. specializes in the research, development, manufacturing, and distribution of medical laboratory instruments and diagnostic reagents. The company provides comprehensive solutions for in-vitro diagnostics (IVD), focusing on several key clinical areas including urinalysis, biochemistry, hematology, and chemiluminescence immunoassay. Its product portfolio features high-throughput automated analyzers and integrated laboratory systems designed to enhance diagnostic efficiency and accuracy. DIRUI serves a global market, providing medical institutions and laboratories with a wide range of diagnostic tools, from urine sediment analysis to vaginal secretion testing. The company emphasizes technological innovation and quality control to support clinical decision-making and patient care through reliable laboratory automation and standardized testing protocols.

Recent filings

Filing Released Lang Actions
北京国枫律师事务所关于公司申请创业板公开发行可转换公司债券的法律意见书
Regulatory Filings
2020-06-30 Chinese
安信证券股份有限公司关于公司向不特定对象发行可转换公司债券之发行保荐书
Capital/Financing Update Classification · 100% confidence The document is titled as an "发行保荐书" (Issuance Sponsorship Letter) related to the issuance of convertible bonds by 迪瑞医疗科技股份有限公司. It is issued by 安信证券股份有限公司 as the sponsor and underwriter. The content includes detailed information about the bond issuance, the sponsor's due diligence, legal and regulatory compliance, company background, financial data, and the decision-making process for the issuance. This document is a formal sponsorship letter for a capital raising activity involving convertible bonds, which is a financing update rather than a financial report or audit. It is not an annual or interim report, nor an earnings release or management discussion. It is a detailed document related to capital/financing activities, specifically the issuance of convertible bonds to unspecified investors. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length (15,000 characters) and detailed content confirm it is the actual sponsorship document, not just an announcement or a brief notice.
2020-06-30 Chinese
关于向不特定对象发行可转换公司债券申请获得深圳证券交易所受理的公告
Capital/Financing Update Classification · 95% confidence The document is a short announcement from a company about the acceptance of its application to issue convertible bonds by the Shenzhen Stock Exchange. It mentions regulatory review and the need for further approvals before implementation. The document is brief (601 characters) and does not contain financial statements or detailed financial data. It is an update on a capital raising process, specifically about the acceptance of the application for convertible bond issuance. Therefore, it fits best under Capital/Financing Update (CAP).
2020-06-30 Chinese
安信证券股份有限公司关于公司向不特定对象发行可转换公司债券之创业板上市保荐书
Capital/Financing Update Classification · 95% confidence The document is titled as a "上市保荐书" which translates to a "Listing Sponsorship Letter" or "Sponsorship Document" related to the issuance of convertible bonds by a company (迪瑞医疗科技股份有限公司). It is issued by a securities firm (安信证券股份有限公司) acting as the sponsor and underwriter for the convertible bond issuance. The content includes detailed information about the issuer, the bond issuance, risks, financial data, and the sponsor's commitments. This type of document is a formal underwriting and sponsorship document required for the issuance of securities, specifically convertible bonds, and is not a financial report like an annual or interim report, nor is it a simple announcement or presentation. It is a detailed regulatory filing related to capital raising and financing activities. Therefore, the most appropriate classification is "Capital/Financing Update (CAP)". The document length (15,000 characters) and detailed content support this classification with high confidence.
2020-06-30 Chinese
关于获得发明专利证书的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement from a company about receiving an invention patent certificate. It contains no financial data, no mention of financial results, no regulatory filings related to financial performance, no meeting materials, no voting results, no management changes, no legal proceedings, and no capital or share transactions. The document is an official company announcement about intellectual property rights, which does not fit into any specific financial report category. Given its short length (626 characters) and nature as a formal announcement, it best fits the category of Regulatory Filings (RNS), which is the fallback for miscellaneous official announcements that do not fit other categories.
2020-06-23 Chinese
关于控股子公司获得医疗器械注册证的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement (803 characters) about a subsidiary obtaining a medical device registration certificate issued by a provincial drug regulatory authority. It contains no financial data, no report or financial statements, and no mention of voting results or management changes. It is an operational update related to regulatory approval of a product, not a financial report or meeting material. The document is an official announcement of a regulatory event affecting the company but does not fit into categories like Annual Report, Earnings Release, or Management Reports. It is best classified under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2020-06-18 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.